Business
Opportunity Insights for the $1.1 Billion Preclinical Imaging Industry, 2026 - Bruker Corp., Cubresa, and Siemens Healthineers Lead
Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "Preclinical Imaging Industry Analysis, Size, Share, Growth, Trends, and Forecast 2026-2033 - (by Product Type, Application, End-User, Geographic Coverage and by Company)" has been added to ResearchAndMarkets.com's offering. The global Preclinical Imaging Market is poised for robust growth, with market revenue projected to increase from $1.1 billion in 2026 to $1.7 billion by 2033, reflecting a CAGR of 6.10% during the forecast period. The expansion o
About this update from Bruker Corporation
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/LAb6sww2pvOwp1YOuMHMug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUw/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "Preclinical Imaging Industry Analysis, Size, Share, Growth, Trends, and Forecast 2026-2033 - (by Product Type, Application, End-User, Geographic Coverage and by Company)" has been added to ResearchAndMarkets.com's offering.","length":284,"tagName":"p"},{"type":"text","content":"The global Preclinical Imaging Market is poised for robust growth, with market revenue projected to increase from $1.1 billion in 2026 to $1.7 billion by 2033, reflecting a CAGR of 6.10% during the forecast period. The expansion of this market is fueled by the growing adoption of preclinical imaging techniques in drug discovery, translational research, and biomarker validation, pivotal for enhancing efficiency in pharmaceutical and biotech research.","length":453,"tagName":"p"},{"type":"text","content":"Market Insights","length":15,"tagName":"p"},{"type":"text","content":"Market growth is largely attributed to increasing demand for advanced imaging systems, reagents, and services that support high-throughput and high-resolution studies in preclinical research settings.","length":200,"tagName":"p"},{"type":"text","content":"The adoption of multi-modal imaging systems such as PET, SPECT, CT, MRI, and optical imaging has improved the accuracy and predictive power of preclinical studies. Additionally, the integration of artificial intelligence (AI) and machine learning (ML) in imaging platforms is facilitating automated data analysis and interpretation, further enhancing the utility of these technologies in drug development pipelines.","length":415,"tagName":"p"},{"type":"text","content":"Key Market Drivers","length":18,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Expansion of Drug Discovery Initiatives - Pharmaceutical and biotech companies are investing heavily in preclinical im...